PUBLICATIONS · 37071836
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Jul 1
- First author
- Cartron G
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2023 Sep 1;41(25):4187. doi: 10.1200/JCO.23.01377.
- note
- Source null
- related pmid
- 37450783
- relationship
- Erratum in
Authors and identifiers
- name
- Cartron G
- type
- Author
- name
- Bachy E
- type
- Author
- name
- Tilly H
- type
- Author
- name
- Daguindau N
- type
- Author
- name
- Pica GM
- type
- Author
- name
- Bijou F
- type
- Author
- name
- Mounier C
- type
- Author
- name
- Clavert A
- type
- Author
- name
- Damaj GL
- type
- Author
- name
- Slama B
- type
- Author
- name
- Casasnovas O
- type
- Author
- name
- Houot R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Cartron G
- type
- Author
- name
- Bachy E
- type
- Author
- name
- Tilly H
- type
- Author
- name
- Daguindau N
- type
- Author
- name
- Pica GM
- type
- Author
- name
- Bijou F
- type
- Author
- name
- Mounier C
- type
- Author
- name
- Clavert A
- type
- Author
- name
- Damaj GL
- type
- Author
- name
- Slama B
- type
- Author
- name
- Casasnovas O
- type
- Author
- name
- Houot R
- type
- Author
- bibliography ids
- nci-bib-159d59ee855c5a0604109dba
- book metadata
- content sha256
- dd53f5c882eb9ce73ac65a7e6068b256210ef0fa7071b68f88bff98fdb1ef983
- document type
- citation
- dois
- 10.1200/JCO.22.02327
- electronic publication date
- display
- 2023 Apr 18
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37071836
- immutable id
- pubmed:37071836@dd53f5c882eb9ce73ac65a7e6068b256210ef0fa7071b68f88bff98fdb1ef983
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3523-3533
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2023 Sep 1;41(25):4187. doi: 10.1200/JCO.23.01377.
- note
- Source null
- related pmid
- 37450783
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 37071836
- provenance
- batch id
- 5329a5d0877ee70ecd11
- provider
- NCBI PubMed ESummary
- record sha256
- a6c723191dca550f7474e595844cb2f925e0891868620350ca52dda9adc66d6b
- response sha256
- bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
- retrieved at
- 2026-09-09T23:48:15.763286+00:00
- publication date
- display
- 2023 Jul 1
- precision
- day
- year
- 2023
- publication types
- Randomized Controlled Trial
- Clinical Trial, Phase III
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle